Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Paul Viard

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
Antiviral Therapy|May 17, 2007
Reversibility of cirrhosis in HIV/HBV coinfectionVincent O Mallet, Valérie Dhalluin-Venier, Virginie Verkarre, et al.
BMC Public Health|October 10, 2025
Sexual health indicators among young adults living with perinatally-acquired HIV in france, a gender-stratified comparison with their peers in the general populationNour Ibrahim, Jean Bouyer, Catherine Dollfus, et al.
Gastroenterologie Clinique Et Biologique|January 2, 2008
Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosisFanny Lanternier, Dominique Roulot, Michele Bentata, et al.
Plos One|February 9, 2021
Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening methodBenoît Heid-Picard, Béatrix Cochand-Priollet, Flore Rozenberg, et al.
AIDS (London, England)|June 11, 2009
Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patientsVincent O Mallet, Aditi Varthaman, Dominique Lasne, et al.
AIDS (London, England)|September 14, 2013
Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopeniaLambert Assoumou, Christine Katlama, Jean-Paul Viard, et al.
AIDS (London, England)|April 20, 2004
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA levelJean-Paul Viard, Marianne Burgard, Jean-Baptiste Hubert, et al.
AIDS Research and Therapy|April 5, 2016
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trialNathalie de Castro, Joséphine Braun, Isabelle Charreau, et al.
Plos One|December 16, 2016
No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected AdultsJean-Paul Viard, Alex Assuied, Yves Lévy, et al.
Retrovirology|December 24, 2025
Strand-specific detection of cell-associated sense and antisense HIV-1 RNAs in splenocytes and PBMC from PLWHLaetitia Waast, Aurélien Geronimi, Adeline Mélard, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Antiviral Therapy|May 17, 2007
Reversibility of cirrhosis in HIV/HBV coinfectionVincent O Mallet, Valérie Dhalluin-Venier, Virginie Verkarre, et al.
BMC Public Health|October 10, 2025
Sexual health indicators among young adults living with perinatally-acquired HIV in france, a gender-stratified comparison with their peers in the general populationNour Ibrahim, Jean Bouyer, Catherine Dollfus, et al.
Gastroenterologie Clinique Et Biologique|January 2, 2008
Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosisFanny Lanternier, Dominique Roulot, Michele Bentata, et al.
Plos One|February 9, 2021
Ambulatory anal self-sampling in MSM living with HIV, an acceptable and reliable screening methodBenoît Heid-Picard, Béatrix Cochand-Priollet, Flore Rozenberg, et al.
AIDS (London, England)|June 11, 2009
Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patientsVincent O Mallet, Aditi Varthaman, Dominique Lasne, et al.
AIDS (London, England)|September 14, 2013
Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopeniaLambert Assoumou, Christine Katlama, Jean-Paul Viard, et al.
AIDS (London, England)|April 20, 2004
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA levelJean-Paul Viard, Marianne Burgard, Jean-Baptiste Hubert, et al.
AIDS Research and Therapy|April 5, 2016
Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trialNathalie de Castro, Joséphine Braun, Isabelle Charreau, et al.
Plos One|December 16, 2016
No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected AdultsJean-Paul Viard, Alex Assuied, Yves Lévy, et al.
Retrovirology|December 24, 2025
Strand-specific detection of cell-associated sense and antisense HIV-1 RNAs in splenocytes and PBMC from PLWHLaetitia Waast, Aurélien Geronimi, Adeline Mélard, et al.
Pageof 14